As anticipated, overexpression of SRSF11 in HCC cells promoted cell proliferation and survival upon IR, whereas TET treatment-induced SRSF11 re-silencing markedly exacerbated this severe impairment (Supplementary Fig. 3a, b). This evidence concerns the gene SRSF11 and hepatocellular carcinoma.